Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 3.0 | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.82 | 1.81 |
NAV | ₹134.36 | ₹99.30 |
Fund Started | 30 Aug 2005 | 31 Jul 2008 |
Fund Size | ₹7728.52 Cr | ₹4721.61 Cr |
Exit Load | Exit load of 1%, if redeemed within 90 days. | Exit load of 1%, if redeemed within 30 days. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 28.59% | 40.29% |
3 Year | 12.58% | 23.65% |
5 Year | 16.74% | 23.58% |
1 Year
3 Year
5 Year
Equity | 94.83% | 97.40% |
Cash | 5.17% | 2.60% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
ICICI Bank Ltd. | 8.55% |
HDFC Bank Ltd. | 6.61% |
Infosys Ltd. | 6.40% |
Bharti Airtel Ltd. | 5.39% |
Reliance Industries Ltd. | 4.80% |
NTPC Ltd. | 4.59% |
Larsen & Toubro Ltd. | 4.42% |
Coforge Ltd. | 3.77% |
Axis Bank Ltd. | 3.75% |
Mahindra & Mahindra Ltd. | 3.73% |
Name | Assets |
---|---|
HDFC Bank Ltd. | 6.21% |
ICICI Bank Ltd. | 5.26% |
State Bank of India | 4.04% |
Infosys Ltd. | 3.90% |
Larsen & Toubro Ltd. | 2.88% |
Bharti Airtel Ltd. | 2.83% |
Dr. Reddy's Laboratories Ltd. | 2.73% |
ITC Ltd. | 2.54% |
CESC Ltd. | 2.29% |
Biocon Ltd. | 2.21% |
Name | Dhaval Joshi | Satish Ramanathan |
Start Date | 21 Nov 2022 | 01 Oct 2024 |
Name
Start Date
Description | The Scheme seeks to achieve long term capital appreciation by investing in upto 30 companies with long term sustainable competitive advantage and growth potential | The scheme which aims to provide capital appreciation by investing primarily in equity and equity related securities of various market depending upon valuation discount or premium amongst Large / Mid & Small cap stocks, the fund will keep varying the weights to capture the value while keeping an optimum Risk / Return profile. |
Launch Date | 30 Aug 2005 | 31 Jul 2008 |
Description
Launch Date